Update
$Amneal Pharmaceuticals (AMRX.US)$ Reuters
4 mins ago
Amneal Receives U.S. FDA Approval for Ipx203 for Treatment of Parkinson’s Disease to Be Launched as Crexont® (Carbidopa and Levodopa) Extended-Release Capsules
4 mins ago
Amneal Receives U.S. FDA Approval for Ipx203 for Treatment of Parkinson’s Disease to Be Launched as Crexont® (Carbidopa and Levodopa) Extended-Release Capsules
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
